K. E. Matthys

973 total citations
18 papers, 779 citations indexed

About

K. E. Matthys is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Biochemistry. According to data from OpenAlex, K. E. Matthys has authored 18 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Biochemistry. Recurrent topics in K. E. Matthys's work include Nitric Oxide and Endothelin Effects (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Antioxidant Activity and Oxidative Stress (5 papers). K. E. Matthys is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Antioxidant Activity and Oxidative Stress (5 papers). K. E. Matthys collaborates with scholars based in Belgium, Netherlands and France. K. E. Matthys's co-authors include Hidde Bult, K. Van Acker, Ides M. Colin, Chantal Mathieu, Didier Bouhassira, Dirk De Bacquer, Arnold G. Herman, Philippe G. Jorens, J.-C. Stolear and Norbert Lameire and has published in prestigious journals such as European Heart Journal, Arteriosclerosis Thrombosis and Vascular Biology and British Journal of Pharmacology.

In The Last Decade

K. E. Matthys

18 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. E. Matthys Belgium 11 370 204 140 124 87 18 779
Angelika D. Manthripragada United States 12 79 0.2× 351 1.7× 260 1.9× 48 0.4× 136 1.6× 19 977
Ametov As Russia 10 482 1.3× 379 1.9× 83 0.6× 336 2.7× 199 2.3× 149 1.1k
Mary Keith Canada 14 271 0.7× 159 0.8× 131 0.9× 73 0.6× 216 2.5× 24 1.1k
Dandan Gong China 16 98 0.3× 118 0.6× 60 0.4× 45 0.4× 202 2.3× 52 850
Rahul Yadav India 12 321 0.9× 141 0.7× 269 1.9× 221 1.8× 79 0.9× 43 836
Giulia Paroni Italy 16 305 0.8× 24 0.1× 75 0.5× 30 0.2× 145 1.7× 42 787
Charlene Bierl United States 13 348 0.9× 31 0.2× 108 0.8× 54 0.4× 433 5.0× 18 1.2k
Heung Yong Jin South Korea 17 292 0.8× 126 0.6× 200 1.4× 515 4.2× 218 2.5× 74 1.1k
Yoshihito Fujita Japan 22 282 0.8× 67 0.3× 342 2.4× 481 3.9× 738 8.5× 74 1.6k
Cristina Bosi Italy 20 309 0.8× 82 0.4× 97 0.7× 73 0.6× 280 3.2× 32 1.0k

Countries citing papers authored by K. E. Matthys

Since Specialization
Citations

This map shows the geographic impact of K. E. Matthys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. E. Matthys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. E. Matthys more than expected).

Fields of papers citing papers by K. E. Matthys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. E. Matthys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. E. Matthys. The network helps show where K. E. Matthys may publish in the future.

Co-authorship network of co-authors of K. E. Matthys

This figure shows the co-authorship network connecting the top 25 collaborators of K. E. Matthys. A scholar is included among the top collaborators of K. E. Matthys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. E. Matthys. K. E. Matthys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Acker, K. Van, Didier Bouhassira, Dirk De Bacquer, et al.. (2009). Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes & Metabolism. 35(3). 206–213. 312 indexed citations
2.
Bouhassira, Didier, et al.. (2007). 260 PREVALENCE OF POLYNEUROPATHY WITH OR WITHOUT NEUROPATHIC PAIN IN TYPE 1 AND 2 DIABETIC PATIENTS. European Journal of Pain. 11(S1). 3 indexed citations
3.
Sutter, Johan De, Dirk De Bacquer, Luc Jordaens, et al.. (2006). Intensive lipid-lowering therapy and ventricular arrhythmias in patients with coronary artery disease and internal cardioverter defibrillator implants. European Heart Journal. 27. 946–946. 1 indexed citations
4.
Verbanck, J., et al.. (2006). SYMPTOMATIC HYPOGLYCEMIA IN A PATIENT WITH CHRONIC HEMODIALYSIS. Acta Clinica Belgica. 61(5). 249–251. 2 indexed citations
5.
Sutter, Johan De, René Tavernier, Dirk De Bacquer, et al.. (2005). Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants. International Journal of Cardiology. 112(1). 72–79. 2 indexed citations
6.
Vrijens, Bernard, Ann Belmans, K. E. Matthys, Erik de Klerk, & Emmanuel Lesaffre. (2005). Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once‐daily atorvastatin. Pharmacoepidemiology and Drug Safety. 15(2). 115–121. 68 indexed citations
7.
Lins, R., K. E. Matthys, Jean-Marie Billiouw, et al.. (2004). Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study. Clinical Nephrology. 62(10). 287–294. 29 indexed citations
8.
Lins, R., K. E. Matthys, Gert A. Verpooten, et al.. (2003). Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients. Nephrology Dialysis Transplantation. 18(5). 967–976. 106 indexed citations
9.
Bult, Hidde, Arnold G. Herman, & K. E. Matthys. (1999). Antiatherosclerotic activity of drugs in relation to nitric oxide function. European Journal of Pharmacology. 375(1-3). 157–176. 26 indexed citations
10.
Matthys, K. E., et al.. (1999). Involvement of 5‐HT1B receptors in collar‐induced hypersensitivity to 5‐hydroxytryptamine of the rabbit carotid artery. British Journal of Pharmacology. 127(6). 1327–1336. 13 indexed citations
11.
Herman, A.G., et al.. (1999). Oxidized low-density lipoprotein enhances intimal thickening and alters vascular reactivity.. PubMed. 61(1). 19–36; discussion 36. 1 indexed citations
13.
Matthys, K. E. & Hidde Bult. (1997). Nitric oxide function in atherosclerosis. Mediators of Inflammation. 6(1). 3–21. 68 indexed citations
14.
Matthys, K. E., Cor E. Van Hove, Mark Kockx, et al.. (1997). Local Application of LDL Promotes Intimal Thickening in the Collared Carotid Artery of the Rabbit. Arteriosclerosis Thrombosis and Vascular Biology. 17(11). 2423–2429. 21 indexed citations
15.
Zamora, Rubén, K. E. Matthys, & Arnold G. Herman. (1997). The protective role of thiols against nitric oxide-mediated cytotoxicity in murine macrophage J774 cells. European Journal of Pharmacology. 321(1). 87–96. 34 indexed citations
16.
Matthys, K. E., Cor E. Van Hove, Philippe G. Jorens, et al.. (1996). Dual effects of oxidized low-density lipoprotein on ommune-stimulated nitric oxide and prostaglandin release in macrophages. European Journal of Pharmacology. 298(1). 97–103. 9 indexed citations
17.
Jorens, Philippe G., K. E. Matthys, & Hidde Bult. (1995). Modulation of nitric oxide synthase activity in macrophages. Mediators of Inflammation. 4(2). 75–89. 62 indexed citations
18.
Matthys, K. E., Philippe G. Jorens, Bart Marescau, et al.. (1994). Oxidized Lipoproteins Suppress Nitric Oxide Synthase in Macrophages:Study of Glucocorticoid Receptor Involvement. Mediators of Inflammation. 3(5). 323–327. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026